公司資料
Olink 股價、新聞與催化劑
- 股票代碼:
- OLK
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for OLK.
公司概覽
業務概覽
Olink was a proteomics platform company focused on high-throughput protein biomarker analysis before being acquired by Thermo Fisher Scientific.
所在地與產業分類
Headquartered in Sweden and listed in the United States before acquisition, it sat in life-sciences tools.
商業模式特徵
The business was driven by proteomics instrument demand, consumables, and adoption in research and translational science.
生技產業定位
Olink was a premium proteomics tools name and is now best viewed through the lens of biotech infrastructure M&A.
未來催化劑
- Olink is now largely a Thermo Fisher integration and proteomics-adoption story, with catalysts tied to broader platform usage inside a much bigger life-science footprint. The stock matters mainly if protein-biomarker workflows keep scaling.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。